Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIX
3401
Western Asset High Income Fund II
HIX
$349M
| $167K | ﹤0.01% |
33,285
+11,083
| +50% | +$69.9K |
|
|
NBSE
3402
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $167K | ﹤0.01% |
1,172
-261
| -18% | -$34.5K |
|
|
CRESY
3403
Cresud
CRESY
$789M
| $166K | ﹤0.01% |
49,782
+32,078
| +181% | +$153K |
|
|
FBZ
3404
DELISTED
First Trust Brazil AlphaDEX Fund
FBZ
| $165K | ﹤0.01% |
19,520
-14,989
| -43% | -$220K |
|
3405
X4 Pharmaceuticals
XFOR
$413M
| $165K | ﹤0.01% |
552
-1,659
| -75% | -$471K |
|
3406
YPF Sociedad Anonima ADS
YPF
$19.4B
| $165K | ﹤0.01% |
39,586
-114,734
| -74% | -$931K |
|
|
RUHN
3407
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
| $165K | ﹤0.01% |
37,623
+16,904
| +82% | +$125K |
|
|
TGI
3408
DELISTED
Triumph Group
TGI
| $164K | ﹤0.01% |
24,334
-43,124
| -64% | -$788K |
|
|
SRNE
3409
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $164K | ﹤0.01% |
+89,093
| New | +$257K |
|
3410
Green Brick Partners
GRBK
$3.12B
| $163K | ﹤0.01% |
20,286
-66,883
| -77% | -$708K |
|
3411
Newmark Group
NMRK
$2.86B
| $163K | ﹤0.01% |
38,320
+22,814
| +147% | +$224K |
|
3412
Sabesp
SBS
$16.6B
| $163K | ﹤0.01% |
114,088
-804,330
| -88% | -$1.97M |
|
3413
Capital Bancorp
CBNK
$591M
| $162K | ﹤0.01% |
12,963
-1,755
| -12% | -$23.5K |
|
|
REV
3414
DELISTED
Revlon, Inc.
REV
| $162K | ﹤0.01% |
14,809
-13,886
| -48% | -$254K |
|
3415
OP Bancorp
OPBK
$226M
| $161K | ﹤0.01% |
21,527
-1,057
| -5% | -$9.61K |
|
|
MGI
3416
DELISTED
MoneyGram International, Inc. New
MGI
| $161K | ﹤0.01% |
122,725
-381,723
| -76% | -$804K |
|
|
INWK
3417
DELISTED
InnerWorkings, Inc.
INWK
| $161K | ﹤0.01% |
+137,957
| New | +$493K |
|
|
CO
3418
DELISTED
Global Cord Blood Corporation
CO
| $161K | ﹤0.01% |
50,590
-40,397
| -44% | -$177K |
|
3419
CALL
Insmed
INSM
$27.5B
| $160K | ﹤0.01% |
10,000
-90,000
| -90% | -$2.13M |
|
3420
CALL
MacroGenics
MGNX
$266M
| $160K | ﹤0.01% |
27,500
-272,500
| -91% | -$2.47M |
|
3421
Natural Health Trends
NHTC
$14.8M
| $160K | ﹤0.01% |
48,582
-12,555
| -21% | -$50.9K |
|
|
UCTT
3422
Ultra Clean Holdings
UCTT
$3.3B
| $160K | ﹤0.01% |
11,619
-67,532
| -85% | -$1.43M |
|
|
CALA
3423
DELISTED
Calithera Biosciences, Inc
CALA
| $157K | ﹤0.01% |
1,771
-15,339
| -90% | -$1.83M |
|
3424
Genasys
GNSS
$76.5M
| $155K | ﹤0.01% |
47,280
+24,513
| +108% | +$78.3K |
|
3425
CoreCivic
CXW
$3.29B
| $154K | ﹤0.01% |
+13,809
| New | +$207K |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.